1. Home
  2. STOK vs CCS Comparison

STOK vs CCS Comparison

Compare STOK & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$32.81

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Century Communities Inc.

CCS

Century Communities Inc.

HOLD

Current Price

$55.61

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
CCS
Founded
2014
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
STOK
CCS
Price
$32.81
$55.61
Analyst Decision
Strong Buy
Buy
Analyst Count
10
6
Target Price
$39.20
$70.50
AVG Volume (30 Days)
795.5K
211.7K
Earning Date
05-12-2026
04-22-2026
Dividend Yield
N/A
2.02%
EPS Growth
92.73
N/A
EPS
N/A
4.86
Revenue
$184,420,000.00
$4,117,816,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$82.05
$10.84
P/E Ratio
N/A
$11.81
Revenue Growth
404.50
N/A
52 Week Low
$5.35
$50.42
52 Week High
$40.22
$76.00

Technical Indicators

Market Signals
Indicator
STOK
CCS
Relative Strength Index (RSI) 46.53 29.16
Support Level $31.02 $51.84
Resistance Level $35.75 $57.48
Average True Range (ATR) 2.42 1.69
MACD -0.29 -0.00
Stochastic Oscillator 28.66 19.36

Price Performance

Historical Comparison
STOK
CCS

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

Share on Social Networks: